Therapy News and Research

RSS

Researchers study hand movements of symptomatic and asymptomatic athletes after concussion

Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.

9 Dec 2019

Short-term exercise could help to reduce side-effects of prostate hormone therapy

A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research from the University of East Anglia.

9 Dec 2019

High HIV infection rates attributed to transgender community's social stigmatization and isolation

Although HIV infection rates are high among the transgender community in Russia, many transgender people know very little about the virus, as well as their own health status.

9 Dec 2019

Venetoclax in combination with azacytidine aids therapy for myelodysplastic syndromes

A new study by Yale Cancer Center and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.

9 Dec 2019

Inpatient psychiatric hospitalization is associated with reduced suicidality, shows study

When an adolescent is acutely suicidal and cannot safely remain in the community, inpatient psychiatric hospitalization is the traditional intervention.

9 Dec 2019

Study identifies genetic variation linked to heart failure risk in people of African, Latino ancestry

A genetic variation believed to increase risk for heart failure in people of African or Latino ancestry has been identified in a new study by researchers from the Icahn School of Medicine at Mount Sinai and Perelman School of Medicine at the University of Pennsylvania.

9 Dec 2019

Hitachi signs agreement to provide CNAO with proton therapy system

Hitachi, Ltd. has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica with its proton therapy system.

9 Dec 2019

PENTAX Medical raises $125,000 for World Cancer Research Fund through its MILES FOR HEALTH campaign

PENTAX Medical, a leading provider of endo-imaging solutions, celebrates the 100th anniversary of the foundation of Asahi Optical Joint Stock Co., the original manufacturer of PENTAX-branded products.

From PENTAX Medical Company 9 Dec 2019

New partnership enables launch of POCare cell therapy platform within HYGEIA Group’s hospital network

Orgenesis Inc., a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary Masthercell Global, Inc., as well as localized point-of-care development and processing centers for therapeutic treatments, today announces a strategic partnership agreement between the HYGEIA Group and the Theracell–Orgenesis joint venture.

9 Dec 2019

Next-generation sequencing can detect genetic alterations specific to follicular lymphoma

People with follicular lymphoma, a slow-growing lymphatic-system cancer, who have been treated and are in remission for at least two years, may no longer have what has been considered an incurable disease based on highly sensitive testing.

9 Dec 2019

Facial injuries related to cell phones have risen steeply

National emergency room data analysis has shown that number of injuries related to cell phones has risen in the last 20 years.

9 Dec 2019

Computer betting game can help predict the likelihood of opioid reuse

A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.

8 Dec 2019

$Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission$

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission.

8 Dec 2019

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients' bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

8 Dec 2019

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912.

8 Dec 2019

Identifying the type of pain in adults with sickle cell disease may help improve treatment

Identifying the type of pain an adult with sickle cell disease experiences may be useful in improving treatment, according to a new study by researchers at Yale Cancer Center and Smilow Cancer Hospital.

8 Dec 2019

The role of adenosine in neurodegeneration and brain regeneration

The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis.

8 Dec 2019

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

8 Dec 2019

Nanosize container can slip inside cells and deliver medicines, gene therapies

Scientists at Johns Hopkins Medicine report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size - even hefty ones attached to the gene-editing tool called CRISPR.

6 Dec 2019

Pilot clinical trial tests new treatment for type 1 diabetes

Type 1 diabetes is a chronic condition in which the body's own immune system attacks and destroys beta cells in the pancreas. Once the beta cells are destroyed, the pancreas can no longer produce insulin. Currently, there is no cure for T1D and treatment focuses on managing blood sugar levels.

6 Dec 2019

Therapy News and Research

Researchers study hand movements of symptomatic and asymptomatic athletes after concussion

Short-term exercise could help to reduce side-effects of prostate hormone therapy

High HIV infection rates attributed to transgender community's social stigmatization and isolation

Venetoclax in combination with azacytidine aids therapy for myelodysplastic syndromes

Inpatient psychiatric hospitalization is associated with reduced suicidality, shows study

Study identifies genetic variation linked to heart failure risk in people of African, Latino ancestry

Hitachi signs agreement to provide CNAO with proton therapy system

PENTAX Medical raises $125,000 for World Cancer Research Fund through its MILES FOR HEALTH campaign

New partnership enables launch of POCare cell therapy platform within HYGEIA Group’s hospital network

Next-generation sequencing can detect genetic alterations specific to follicular lymphoma

Facial injuries related to cell phones have risen steeply

Computer betting game can help predict the likelihood of opioid reuse

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Identifying the type of pain in adults with sickle cell disease may help improve treatment

The role of adenosine in neurodegeneration and brain regeneration

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

Nanosize container can slip inside cells and deliver medicines, gene therapies

Pilot clinical trial tests new treatment for type 1 diabetes

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News